Major Depressive Disorder - Pipeline Review, H2 2013 - New Study Released
Global Markets Direct's, 'Major Depressive Disorder - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Major Depressive Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Major Depressive Disorder. Major Depressive Disorder - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release